- Home
- LITM vs INKT Comparison
LITM vs INKT Comparison
Compare LITM & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LITM | INKT |
|---|---|---|
| Founded | 2018 | 2017 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.6M | 57.6M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LITM | INKT |
|---|---|---|
| Price | $3.83 | $12.42 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 433.5K | 10.7K |
| Earning Date | 10-31-2025 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.34 | $4.56 |
| 52 Week High | $13.78 | $76.00 |
Technical Indicators
Market Signals| Indicator | LITM | INKT |
|---|---|---|
| Relative Strength Index (RSI) | 55.79 | 55.04 |
| Support Level | $3.10 | $11.56 |
| Resistance Level | $3.70 | $12.31 |
| Average True Range (ATR) | 0.34 | 0.50 |
| MACD | -0.01 | 0.09 |
| Stochastic Oscillator | 73.26 | 75.31 |
Price Performance
Historical ComparisonAbout LITM Snow Lake Resources Ltd.
Snow Lake Resources Ltd is a Canadian nuclear fuel cycle and critical minerals company with a portfolio of U.S.-focused uranium projects, including the Pine Ridge Uranium Project in the Powder River Basin in Wyoming. The company also holds exploration-stage critical minerals projects including the Snow Lake Lithium Project, Shatford Lake Lithium Project, and Engo Valley Uranium Project in Manitoba, Canada, and Namibia. Snow Lake has investments in companies with critical minerals assets, including rare earths and lithium in North America. The primary commercial use for U3O8 is as fuel for nuclear power plants to generate electricity.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.